文献速递主动脉疾病

预防性栓塞瘤囊侧支预防EVAR后II型内漏并促进瘤囊缩小

Type II endoleak and aortic aneurysm sac shrinkage after preemptive embolization of aneurysm sac side branches.
PubMed 文献 · J Vasc Surg · 2020-12-02

该研究纳入139例腹主动脉瘤患者,在EVAR前进行预防性瘤囊侧支栓塞,随访平均23±16个月,结果显示T2EL发生率为5%,86.7%的患者出现瘤囊缩小,平均直径减少9.2±7.7 mm(P < .001),提示该策略安全有效。

要点

  • 预防性栓塞瘤囊侧支后T2EL发生率低(5%),且无重大操作相关并发症。
  • 多数患者(86.7%)出现瘤囊缩小,平均直径减少9.2±7.7 mm。
  • 栓塞后残留通畅的侧支数量是T2EL的唯一判别因素。

核心结论

  • 对腹主动脉瘤患者行预防性瘤囊侧支栓塞安全有效,可预防EVAR后T2EL并促进瘤囊缩小。

研究设计与样本

  • 回顾性队列研究,纳入2014年9月至2019年9月共139例接受EVAR前经皮瘤囊侧支栓塞的腹主动脉瘤患者。

主要发现

  • 平均随访23±16个月,T2EL发生7例(5%),其中6例瘤囊增大。
  • 随访期间行6例T2EL相关再干预,30天内发生1例动脉瘤相关死亡。
  • 86.7%(91例)患者出现瘤囊缩小,平均直径减少9.2±7.7 mm(P < .001)。
  • 栓塞后76.4%的初始通畅侧支被闭塞,无重大操作相关并发症。
  • 栓塞后残留通畅侧支数量是T2EL的唯一判别因素。

临床怎么用

  • 对于接受EVAR的腹主动脉瘤患者,可考虑术前预防性栓塞瘤囊侧支以降低T2EL风险。
  • 术后随访应关注残留通畅侧支数量及瘤囊直径变化。

局限性

  • 回顾性设计,样本量有限(139例),随访时间平均23个月,缺乏对照组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Type II endoleak (T2EL) is the most common endoleak after endovascular aneurysm repair (EVAR). Its optimal management has been controversially discussed. Thus, preliminary selective embolization of aneurysm sac side branches (ASSBs) has been adopted to prevent T2EL. Our goal was to determine the rate of T2EL and the diameter decrease of abdominal aortic aneurysms (AAAs) after EVAR performed after preemptive embolization of ASSBs. METHODS: From September 2014 to September 2019, 139 patients with AAAs underwent percutaneous ASSB embolization before EVAR. Follow-up imaging studies were performed at 1 and 6 months and annually thereafter. The end points included freedom from T2EL, AAA sac shrinkage, T2EL-related reinterventions, and all-cause mortality. RESULTS: The mean follow-up was 23 ± 16 months (range, 1-61 months). The patients had had a median of five (range, one to eight) patent ASSBs found on preoperative imaging studies. After completion of embolization, 76.4% of the initially patent ASSBs were occluded, with no major procedure-related complications. Follow-up imaging studies showed T2ELs in seven patients (5%), with an aneurysm sac increase seen in six of these patients. The number of ASSBs remaining patent after embolization was the only discriminative factor in patients with and without T2EL. Six T2EL-related reinterventions were performed during follow-up. Most patients (n = 91; 86.7%) had experienced aneurysm sac shrinkage, and the mean diameter reduction was 9.2 ± 7.7 mm (P < .001) in all patients with follow-up data available. One aneurysm-related death occurred within 30 days after EVAR. CONCLUSIONS: Preemptive embolization of ASSBs for patients with AAAs is safe and effective in preventing T2ELs after EVAR. Aneurysm sac shrinkage was observed in a high proportion of patients.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Branzan D, Geisler A, Steiner S, et al. Type II endoleak and aortic aneurysm sac shrinkage after preemptive embolization of aneurysm sac side branches. J Vasc Surg. 2020. PMID: 33278537. doi:10.1016/j.jvs.2020.11.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。